|
|||||
|
|
Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism |
|
| Authors: | Todd W. Swanson Simon K. Chan Steven J. Jones Samuel Bugis Robert Irvine Allan Belzberg Daniel Levine Sam M. Wiseman |
| Affiliation: | a Department of Surgery, St Paul's Hospital & University of British Columbia, Vancouver, BC, Canada c Department of Nuclear Medicine, St Paul's Hospital & University of British Columbia, Vancouver, BC, Canada b Department of Medical Genetics, University of British Columbia, British Columbia Cancer Agency and Michael Smith Genome Sciences Center, Vancouver, BC, Canada |
| Abstract: | BackgroundThe aim of this study was to evaluate the influence of patient and adenoma characteristics on 99mTc-methoxy isobutyl isonitrile (MIBI) scan performance in individuals diagnosed with primary hyperparathyroidism (PHP).MethodsRecords of patients undergoing parathyroidectomy for PHP over 6 years at a single center were reviewed.ResultsThe overall true-positive (TP) rate for 99mTc-MIBI scans was 56%. Adenomas sized 1.9 to 3.5 cm were more likely to have TP scans than 0.3-cm to 1.8-cm adenomas (74% vs 40%, P < .001). Preoperative ionized calcium levels between 1.49 and 1.72 mmol/L were more likely to have TPs than levels between 1.27 and 1.48 mmol/L (65% vs 47%, P < .05). No single class of medication was shown to significantly effect TP rates. A decrease in TP rate was observed for larger adenomas in patients on ≥1 medication (74% vs 65%, P = .05).ConclusionsIn PHP, 99mTc-MIBI scan positivity is most related to adenoma size and preoperative ionized calcium level. |
| Keywords: | Primary hyperparathyroidism Sestamibi scan Parathyroid surgery |
| 本文献已被 ScienceDirect 等数据库收录！ | |